Literature DB >> 15543465

The influence of voluntary tonic EMG level on the vestibular-evoked myogenic potential.

Faith W Akin1, Owen D Murnane, Peter C Panus, Stacy K Caruthers, Amy E Wilkinson, Tina M Proffitt.   

Abstract

Vestibular-evoked myogenic potentials (VEMPs) are proposed as a reliable test to supplement the current vestibular test battery by providing diagnostic information about saccular and/or inferior vestibular nerve function. VEMPs are short-latency electromyograms (EMGs) evoked by high-level acoustic stimuli and recorded from surface electrodes over the tonically contracted sternocleidomastoid muscle. VEMP amplitude is influenced by the EMG level, which must be controlled. This study examined the ability of subjects to achieve the EMG target levels over a range of target levels typically used during VEMP recordings. In addition, the influence of target EMG level on the latency and amplitude of the click- and tone-evoked VEMP was examined. The VEMP amplitude increased as a function of EMG target level, and the latency remained constant. EMG target levels ranging from 30 microV to 50 microV are suggested for clinical application of the VEMP.

Entities:  

Mesh:

Year:  2004        PMID: 15543465     DOI: 10.1682/jrrd.2003.04.0060

Source DB:  PubMed          Journal:  J Rehabil Res Dev        ISSN: 0748-7711


  22 in total

1.  Asymmetries in vestibular evoked myogenic potentials in chronic stroke survivors with spastic hypertonia: evidence for a vestibulospinal role.

Authors:  Derek M Miller; Cliff S Klein; Nina L Suresh; William Z Rymer
Journal:  Clin Neurophysiol       Date:  2014-03-12       Impact factor: 3.708

2.  Comparison of chirp versus click and tone pip stimulation for cervical vestibular evoked myogenic potentials.

Authors:  Bo-Chen Wang; Yong Liang; Xiao-Long Liu; Jing Zhao; You-Li Liu; Yan-Fei Li; Wei Zhang; Qi Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-01       Impact factor: 2.503

3.  Cervical Vestibular Evoked Myogenic Potentials in Menière's Disease: A Comparison of Response Metrics.

Authors:  Kimberley S Noij; Barbara S Herrmann; John J Guinan; Steven D Rauch
Journal:  Otol Neurotol       Date:  2019-03       Impact factor: 2.311

4.  Toward Optimizing Vestibular Evoked Myogenic Potentials: Normalization Reduces the Need for Strong Neck Muscle Contraction.

Authors:  Kimberley S Noij; Barbara S Herrmann; Steven D Rauch; John J Guinan
Journal:  Audiol Neurootol       Date:  2018-01-12       Impact factor: 1.854

5.  Effects of High Sound Exposure During Air-Conducted Vestibular Evoked Myogenic Potential Testing in Children and Young Adults.

Authors:  Amanda I Rodriguez; Megan L A Thomas; Denis Fitzpatrick; Kristen L Janky
Journal:  Ear Hear       Date:  2018 Mar/Apr       Impact factor: 3.570

6.  Utricular dysfunction in patients with orthostatic hypotension.

Authors:  Jae-Gyum Kim; Jeong-Heon Lee; Sun-Uk Lee; Jeong-Yoon Choi; Byung-Jo Kim; Ji-Soo Kim
Journal:  Clin Auton Res       Date:  2022-09-08       Impact factor: 5.625

7.  Vestibular evoked myogenic potential (VEMP) testing: normative threshold response curves and effects of age.

Authors:  Kristen L Janky; Neil Shepard
Journal:  J Am Acad Audiol       Date:  2009-09       Impact factor: 1.664

8.  Vestibular evoked myogenic potentials in normal mice and Phex mice with spontaneous endolymphatic hydrops.

Authors:  Kianoush Sheykholeslami; Cliff A Megerian; Qing Y Zheng
Journal:  Otol Neurotol       Date:  2009-06       Impact factor: 2.311

9.  Cervical vestibular-evoked myogenic potentials: norms and protocols.

Authors:  Suwicha Isaradisaikul; Niramon Navacharoen; Charuk Hanprasertpong; Jaran Kangsanarak
Journal:  Int J Otolaryngol       Date:  2012-04-08

10.  Optimization of Cervical and Ocular Vestibular Evoked Myogenic Potential Testing Using an Impulse Hammer in Adults, Adolescents, and Children.

Authors:  Amanda I Rodriguez; Elizabeth Marler; Denis Fitzpatrick; Thomas Creutz; Shauntelle A Cannon; Megan L A Thomas; Kristen L Janky
Journal:  Otol Neurotol       Date:  2020-07       Impact factor: 2.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.